Thomas Pieber, MD

Thomas Pieber, MD, is the chair of the Division of Endocrinology and Diabetology at the Department of Internal Medicine at the Medical University of Graz.

Articles by Thomas Pieber, MD

Investigational Rapid-Acting U500 Insulin Maintains Efficacy Regardless of BMI

ByThomas Pieber, MD

August 17th 2026

Thomas Pieber, MD, discusses a recent phase 1 trial investigating AT278’s efficacy in patients with T2D and obesity compared to other fast-acting insulins.

Thomas Pieber, MD

Articles by Thomas Pieber, MD

Investigational Rapid-Acting U500 Insulin Maintains Efficacy Regardless of BMI

Latest Updated Articles

Trending on HCPLive

Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy

Q&A: Bimekizumab 2-Year Efficacy by HS Disease Duration, With Raj Chovatiya, MD, PhD

BE HEARD EXT: Bimekizumab Shows Greater Benefit With Earlier Use in HS

Bimekizumab Data Support Case for Earlier Intervention in HS

Recognizing, Diagnosing, and Managing Pediatric Cardiogenic Shock